225 related articles for article (PubMed ID: 36567949)
21. Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis.
Zhao B; Xu Y; Zhao Y; Shen S; Sun Q
Front Oncol; 2020; 10():856. PubMed ID: 32596149
[No Abstract] [Full Text] [Related]
22. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
Zhong G; Lou W; Shen Q; Yu K; Zheng Y
Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
[TBL] [Abstract][Full Text] [Related]
23. Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis.
Li L; Huang H; Zhu M; Wu J
Cancer Manag Res; 2021; 13():2095-2104. PubMed ID: 33688252
[TBL] [Abstract][Full Text] [Related]
24. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC.
Guo Q; Qiu P; Yao Q; Chen J; Lin J
Dis Markers; 2022; 2022():4964793. PubMed ID: 36157217
[TBL] [Abstract][Full Text] [Related]
25. Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation.
Yadav DK; Sharma A; Dube P; Shaikh S; Vaghasia H; Rawal RM
Comput Biol Med; 2022 Oct; 149():106036. PubMed ID: 36096037
[TBL] [Abstract][Full Text] [Related]
26. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
27. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
[TBL] [Abstract][Full Text] [Related]
28. Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
Wang N; Gu Y; Chi J; Liu X; Xiong Y; Zhong C; Wang F; Wang X; Li L
Front Genet; 2021; 12():721873. PubMed ID: 34408776
[No Abstract] [Full Text] [Related]
29. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
[TBL] [Abstract][Full Text] [Related]
30. Identification of invasive key genes in breast cancer by bioinformatics analysis.
Quan Y; Wang S
J BUON; 2020; 25(5):2255-2264. PubMed ID: 33277843
[TBL] [Abstract][Full Text] [Related]
31. Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis.
Lin Z; Peng R; Sun Y; Zhang L; Zhang Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33305312
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic values of spindle checkpoint protein BUB1B in triple negative breast cancer].
Zhang PC; Zhong XR; Zheng H; Li L; Chen F; Shen MJ; Li YJ; Chen H; Cao SY; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):645-649. PubMed ID: 34078054
[No Abstract] [Full Text] [Related]
33. Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis.
Mosharaf MP; Reza MS; Gov E; Mahumud RA; Mollah MNH
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632527
[TBL] [Abstract][Full Text] [Related]
34. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
[TBL] [Abstract][Full Text] [Related]
35. Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis.
Lin Y; Fu F; Lv J; Wang M; Li Y; Zhang J; Wang C
Medicine (Baltimore); 2020 Jan; 99(1):e18445. PubMed ID: 31895772
[TBL] [Abstract][Full Text] [Related]
36. Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis.
Dong P; Yu B; Pan L; Tian X; Liu F
Biomed Res Int; 2018; 2018():2760918. PubMed ID: 30175120
[TBL] [Abstract][Full Text] [Related]
37. Identification of potentially functional circular RNAs hsa_circ_0070934 and hsa_circ_0004315 as prognostic factors of hepatocellular carcinoma by integrated bioinformatics analysis.
Morovat P; Morovat S; Ashrafi AM; Teimourian S
Sci Rep; 2022 Mar; 12(1):4933. PubMed ID: 35322101
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics Analysis Predicts hsa_circ_0026337/miR-197-3p as a Potential Oncogenic ceRNA Network for Non-Small Cell Lung Cancers.
Zhang Q; Kang L; Li X; Li Z; Wen S; Fu X
Anticancer Agents Med Chem; 2022; 22(5):874-886. PubMed ID: 34254931
[TBL] [Abstract][Full Text] [Related]
39. Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer.
Bissanum R; Kamolphiwong R; Navakanitworakul R; Kanokwiroon K
Transl Cancer Res; 2022 Sep; 11(9):3039-3049. PubMed ID: 36237261
[TBL] [Abstract][Full Text] [Related]
40. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
